Minimal change disease screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (5 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
{{Minimal change disease}} | {{Minimal change disease}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{VKG}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for minimal change disease.However, according to International Study of Kidney Disease genetic screening for minimal change disease is recommended when the patient is not responsive to steroids within 4 weeks of the treatment started. | There is insufficient evidence to recommend routine screening for minimal change disease.However, according to International Study of Kidney Disease genetic screening for minimal change disease is recommended when the patient is not responsive to steroids within 4 weeks of the treatment started. | ||
==Screening== | ==Screening== | ||
* There is insufficient evidence to recommend routine screening for minimal change disease. | * There is insufficient evidence to recommend routine screening for minimal change disease.<ref name="VivarelliMassella2017">{{cite journal|last1=Vivarelli|first1=Marina|last2=Massella|first2=Laura|last3=Ruggiero|first3=Barbara|last4=Emma|first4=Francesco|title=Minimal Change Disease|journal=Clinical Journal of the American Society of Nephrology|volume=12|issue=2|year=2017|pages=332–345|issn=1555-9041|doi=10.2215/CJN.05000516}}</ref><ref name="pmid27940460">{{cite journal |vauthors=Vivarelli M, Massella L, Ruggiero B, Emma F |title=Minimal Change Disease |journal=Clin J Am Soc Nephrol |volume=12 |issue=2 |pages=332–345 |date=February 2017 |pmid=27940460 |pmc=5293332 |doi=10.2215/CJN.05000516 |url=}}</ref><ref name="pmid8971906">{{cite journal |vauthors=Tune BM, Lieberman E, Mendoza SA |title=Steroid-resistant nephrotic focal segmental glomerulosclerosis: a treatable disease |journal=Pediatr. Nephrol. |volume=10 |issue=6 |pages=772–8 |date=December 1996 |pmid=8971906 |doi= |url=}}</ref> | ||
* However,according to International Study of Kidney Disease genetic screening for minimal change disease is recommended along with performing a renal biopsy when the patient is not responsive to steroids within 4 weeks of the treatment started. | * However,according to International Study of Kidney Disease genetic screening for minimal change disease is recommended along with performing a renal biopsy when the patient is not responsive to steroids within 4 weeks of the treatment started.<ref name="pmid7205481">{{cite journal |vauthors= |title=The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children |journal=J. Pediatr. |volume=98 |issue=4 |pages=561–4 |date=April 1981 |pmid=7205481 |doi= |url=}}</ref><ref name="pmid17504846">{{cite journal |vauthors=Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J |title=Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated |journal=Nephrol. Dial. Transplant. |volume=22 |issue=8 |pages=2183–93 |date=August 2007 |pmid=17504846 |doi=10.1093/ndt/gfm092 |url=}}</ref> | ||
==References== | ==References== | ||
Latest revision as of 20:56, 10 May 2018
|
Minimal Change Disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Minimal change disease screening On the Web |
|
American Roentgen Ray Society Images of Minimal change disease screening |
|
Risk calculators and risk factors for Minimal change disease screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
There is insufficient evidence to recommend routine screening for minimal change disease.However, according to International Study of Kidney Disease genetic screening for minimal change disease is recommended when the patient is not responsive to steroids within 4 weeks of the treatment started.
Screening
- There is insufficient evidence to recommend routine screening for minimal change disease.[1][2][3]
- However,according to International Study of Kidney Disease genetic screening for minimal change disease is recommended along with performing a renal biopsy when the patient is not responsive to steroids within 4 weeks of the treatment started.[4][5]
References
- ↑ Vivarelli, Marina; Massella, Laura; Ruggiero, Barbara; Emma, Francesco (2017). "Minimal Change Disease". Clinical Journal of the American Society of Nephrology. 12 (2): 332–345. doi:10.2215/CJN.05000516. ISSN 1555-9041.
- ↑ Vivarelli M, Massella L, Ruggiero B, Emma F (February 2017). "Minimal Change Disease". Clin J Am Soc Nephrol. 12 (2): 332–345. doi:10.2215/CJN.05000516. PMC 5293332. PMID 27940460.
- ↑ Tune BM, Lieberman E, Mendoza SA (December 1996). "Steroid-resistant nephrotic focal segmental glomerulosclerosis: a treatable disease". Pediatr. Nephrol. 10 (6): 772–8. PMID 8971906.
- ↑ "The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children". J. Pediatr. 98 (4): 561–4. April 1981. PMID 7205481.
- ↑ Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J (August 2007). "Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated". Nephrol. Dial. Transplant. 22 (8): 2183–93. doi:10.1093/ndt/gfm092. PMID 17504846.